Navigation Links
Clinicians Use Advanced Radiotherapy Imaging Techniques from Elekta to More Accurately Visualize Moving Tumors in Patients with Lung Cancer
Date:10/18/2010

LEEDS, England, Oct. 18 /PRNewswire/ -- A 67-year-old female patient with lung cancer presented physicians with a difficult challenge: her tumor was small and it rode up and down with her breathing. During her treatment set up, all doctors saw on their therapy system's imaging equipment was a blur of motion. Fortunately, Leeds Teaching Hospitals NHS Trust was able to utilize its Symmetry™ motion management software; new imaging technology from Elekta that enables clear visualization of moving targets.

"For this patient, and many similar lung cancer cases, Symmetry is invaluable," says her physician, Kevin N. Franks, M.D., Consultant in Clinical Oncology at St. James Institute of Oncology, Leeds Teaching Hospitals NHS Trust. "Our first patient's tumor was just 1.4 cm in size and its range of motion when she breathed was 2.4 cm because it was close to her diaphragm. Treating a small tumor with this kind of motion would normally have excluded her from aggressive treatments such as Stereotactic Body Radiation Therapy [SBRT], particularly if you can't see it well on imaging studies."

Symmetry provided sufficient scan quality to isolate the "moving" tumor and the patient -- the first at Leeds to benefit from the technique -- received five SBRT treatments, which use precise stereotactic targeting and a potent dose designed to achieve control of the tumor.

Symmetry captures tumor position virtually invisible on static imaging

Symmetry is a feature set of Elekta's X-ray Volume Imaging (XVI) package of software for Image Guided Radiation Therapy (IGRT). The software enables clinicians to add the fourth dimension (i.e. 4D) of motion to enhance image guidance with the patient in the treatment position just before therapy.

Leeds physicians had been able to use their 4D CT scanner to observe the tumor moving with the patient's breathing. However, they were able to see only an ill-defined blur when they used 3D XVI on their Elekta Synergy® system.

"It's like trying to take a picture of a fast-moving object using a camera that has a slow shutter speed," says Jonathan Sykes, Joint Lead Radiotherapy Imaging Physicist at Leeds. "But by taking the 4D CT planning scan -- which showed the 'envelope' of space within which the tumor was moving -- and matching that to 4D Symmetry reconstructions, which show where the tumor is during the breathing cycle, the scan quality was sufficient to localize the tumor."

After this first localization, three-minute 4D Symmetry scans were repeated three times for each of the five treatment sessions to localize the tumor, a second scan to verify needed patient position corrections and a third scan to ensure proper patient immobilization. Of note, the treatments are delivered while the patient is breathing freely.

"The 4D-XVI scan allowed us to see the tumor clearly and check that the tumor motion had not changed from the planning 4D CT scan. It made the team confident of the tumor localization," Dr. Franks says. "Without Symmetry, SBRT might still have been possible as the tumor was distant from critical organs, but we would have had to increase the treatment margins around the tumor to account for the increased uncertainty about the tumor's position. The worst case scenario is not using SBRT and treating her with a conventional technique that is likely less effective."

Since this first patient, Leeds physicians have used Symmetry in treatments of three additional patients with lung cancer. To download a case study detailing the application of Symmetry at Leeds, visit www.elekta.com/proof.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The Lancets New Online Medical Journal Helps Clinicians and Medical Researchers Find Practice-Changing Evidence Quickly and Easily
2. New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema
3. New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices
4. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
5. Advanced Life Sciences Announces Second Quarter 2008 Financial Results
6. LUMEDX Introduces Advanced Multi-Modality, Multi-Vendor, Web-Enabled ECG Management Solution
7. Waters Brings Advanced Laboratory Data Management to Microsofts BioIT Alliance
8. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
9. Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services
10. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
11. Advanced Chemical Transport Opens Merced Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2017)... ... , ... Sourcing custom glass or quartz parts can be a daunting task. ... execute your job can take many hours of emails, phone calls and on-line research. ... showcase the company’s capabilities and core custom categories, and enables you to start the ...
(Date:7/18/2017)... ... July 18, 2017 , ... G-CON today announced ... Trademark Office for its Patent Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, ... applications further expand the protection of G-CON’s R&D investments and validate the G-CON ...
(Date:7/18/2017)... ... July 18, 2017 , ... Allotrope Foundation won the 2017 ... of the Allotrope Framework for commercial use. , The Bio-IT World Best Practices ... elevate the critical role of information technology in modern biomedical research, but also ...
(Date:7/17/2017)... ... July 17, 2017 , ... Whitehouse ... testing capabilities to encompass the full series of ISO 80369 standard test procedures. ... for medical device and drug delivery systems. With this recent expansion, Whitehouse Labs ...
Breaking Biology Technology:
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
Breaking Biology News(10 mins):